BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

521 related articles for article (PubMed ID: 16537624)

  • 1. Adenovirus-mediated RNA interference against foot-and-mouth disease virus infection both in vitro and in vivo.
    Chen W; Liu M; Jiao Y; Yan W; Wei X; Chen J; Fei L; Liu Y; Zuo X; Yang F; Lu Y; Zheng Z
    J Virol; 2006 Apr; 80(7):3559-66. PubMed ID: 16537624
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rapid protection of cattle from direct challenge with foot-and-mouth disease virus (FMDV) by a single inoculation with an adenovirus-vectored FMDV subunit vaccine.
    Pacheco JM; Brum MC; Moraes MP; Golde WT; Grubman MJ
    Virology; 2005 Jul; 337(2):205-9. PubMed ID: 15893355
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of protective immunity in swine by immunization with live attenuated recombinant pseudorabies virus expressing the capsid precursor encoding regions of foot-and-mouth disease virus.
    Li X; Liu R; Tang H; Jin M; Chen H; Qian P
    Vaccine; 2008 May; 26(22):2714-22. PubMed ID: 18436351
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cross-inhibition to heterologous foot-and-mouth disease virus infection induced by RNA interference targeting the conserved regions of viral genome.
    Liu M; Chen W; Ni Z; Yan W; Fei L; Jiao Y; Zhang J; Du Q; Wei X; Chen J; Liu Y; Zheng Z
    Virology; 2005 May; 336(1):51-9. PubMed ID: 15866070
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adenovirus-vectored shRNAs targeted to the highly conserved regions of VP1 and 2B in tandem inhibits replication of foot-and-mouth disease virus both in vitro and in vivo.
    Xu YF; Shen HY; Zhao MQ; Chen LJ; Li YG; Liao M; Jia JT; Lv YR; Yi L; Chen JD
    J Virol Methods; 2012 Apr; 181(1):51-8. PubMed ID: 22327142
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic application of RNA interference against foot-and-mouth disease virus in vitro and in vivo.
    Kim SM; Lee KN; Park JY; Ko YJ; Joo YS; Kim HS; Park JH
    Antiviral Res; 2008 Nov; 80(2):178-84. PubMed ID: 18601955
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Delivery of a foot-and-mouth disease virus empty capsid subunit antigen with nonstructural protein 2B improves protection of swine.
    Pena L; Moraes MP; Koster M; Burrage T; Pacheco JM; Segundo FD; Grubman MJ
    Vaccine; 2008 Oct; 26(45):5689-99. PubMed ID: 18762225
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adenovirus-mediated type I interferon expression delays and reduces disease signs in cattle challenged with foot-and-mouth disease virus.
    Wu Q; Brum MC; Caron L; Koster M; Grubman MJ
    J Interferon Cytokine Res; 2003 Jul; 23(7):359-68. PubMed ID: 14511462
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protection of guinea pigs and swine by a recombinant adenovirus expressing O serotype of foot-and-mouth disease virus whole capsid and 3C protease.
    Lu Z; Bao H; Cao Y; Sun P; Guo J; Li P; Bai X; Chen Y; Xie B; Li D; Liu Z; Xie Q
    Vaccine; 2008 Dec; 26 Suppl 6():G48-53. PubMed ID: 19178894
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Short hairpin RNA targeted to the highly conserved 2B nonstructural protein coding region inhibits replication of multiple serotypes of foot-and-mouth disease virus.
    de los Santos T; Wu Q; de Avila Botton S; Grubman MJ
    Virology; 2005 May; 335(2):222-31. PubMed ID: 15840521
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced antiviral activity against foot-and-mouth disease virus by a combination of type I and II porcine interferons.
    Moraes MP; de Los Santos T; Koster M; Turecek T; Wang H; Andreyev VG; Grubman MJ
    J Virol; 2007 Jul; 81(13):7124-35. PubMed ID: 17459931
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased efficacy of an adenovirus-vectored foot-and-mouth disease capsid subunit vaccine expressing nonstructural protein 2B is associated with a specific T cell response.
    Moraes MP; Segundo FD; Dias CC; Pena L; Grubman MJ
    Vaccine; 2011 Nov; 29(51):9431-40. PubMed ID: 22027486
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of porcine reproductive and respiratory syndrome virus replication by adenovirus-mediated RNA interference both in porcine alveolar macrophages and swine.
    Li G; Jiang P; Li Y; Wang X; Huang J; Bai J; Cao J; Wu B; Chen N; Zeshan B
    Antiviral Res; 2009 Jun; 82(3):157-65. PubMed ID: 19428607
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of replication-defective adenovirus serotype 5 containing the capsid and 3C protease coding regions of foot-and-mouth disease virus as a vaccine candidate.
    Mayr GA; Chinsangaram J; Grubman MJ
    Virology; 1999 Oct; 263(2):496-506. PubMed ID: 10544121
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Constitutively Active IRF7/IRF3 Fusion Protein Completely Protects Swine against Foot-and-Mouth Disease.
    Ramírez-Carvajal L; Diaz-San Segundo F; Ramirez-Medina E; Rodríguez LL; de Los Santos T
    J Virol; 2016 Oct; 90(19):8809-21. PubMed ID: 27466421
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immune responses of recombinant adenovirus co-expressing VP1 of foot-and-mouth disease virus and porcine interferon alpha in mice and guinea pigs.
    Du Y; Dai J; Li Y; Li C; Qi J; Duan S; Jiang P
    Vet Immunol Immunopathol; 2008 Aug; 124(3-4):274-83. PubMed ID: 18511133
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early detection and visualization of human adenovirus serotype 5-viral vectors carrying foot-and-mouth disease virus or luciferase transgenes in cell lines and bovine tissues.
    Montiel N; Smoliga G; Arzt J
    Vaccine; 2012 Feb; 30(9):1690-701. PubMed ID: 22227230
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiple shRNAs driven by U6 and CMV promoter enhances efficiency of antiviral effects against foot-and-mouth disease virus.
    Kim SM; Lee KN; Lee SJ; Ko YJ; Lee HS; Kweon CH; Kim HS; Park JH
    Antiviral Res; 2010 Sep; 87(3):307-17. PubMed ID: 20561543
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of novel strategies to control foot-and-mouth disease: marker vaccines and antivirals.
    Grubman MJ
    Biologicals; 2005 Dec; 33(4):227-34. PubMed ID: 16289996
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of immune responses after intra-typic heterologous and homologous vaccination against foot-and-mouth disease virus infection in pigs.
    Eblé PL; de Bruin MG; Bouma A; van Hemert-Kluitenberg F; Dekker A
    Vaccine; 2006 Feb; 24(9):1274-81. PubMed ID: 16289709
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.